A strain of Yoshida sarcoma with induced resistance to pafencyl


This is a new Soviet antileukemic agent, for use in the treatment of chronic lymphatic leukemia, non-Hodgkin lymphomas, lymphogranulomatosis, Waldenstrom's disease, and multiple myeloma [2]. During chemotherapy of malignant tumors resistance develops to the action of active drugs and, in particular, of alkylating agents. To study the phenomenon and the… (More)
DOI: 10.1007/BF00842758


1 Figure or Table

Slides referencing similar topics